Source: Annual Congress 2004 - Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bacci, A. Di Paco, M. L. Bartoli, E. Garbella, M. Taccola, B. Vagaggini, M. Zingoni, M. De Santis, P. L. Paggiaro (Pisa, Italy). Role of sputum eosinophil levels in the assessment of asthma treatment. Eur Respir J 2004; 24: Suppl. 48, 3558

Member's Comments

No comment yet.

Related content which might interest you: Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Comparison of Nε-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Monitoring of sputum eosinophils in long-term treatment of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006 A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Role of blood neutrophilia as a biomarker in asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 268s Year: 2001 The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Correlation between nasal secretion eosinophilia and induced sputum eosiniphilia in pediatric asthma Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity? Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Sputum eosinophil percentages during a moderate exacerbation of asthma and during a natural cold Source: Eur Respir J 2002; 20: Suppl. 38, 508s Year: 2002 Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Impact on steroid dosing after introducing sputum eosinophils count into a severe asthma clinic Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003